Sunday, September 5, 2010

Cladribine (en) Cladribin (de)Image via WikipediaMerck's Cladribine Tablets For Multiple Sclerosis Approved In Australia
Merck KGaA announced that the Australian Therapeutic Goods Administration (TGA) has approved Cladribine Tablets for the treatment of relapsing-remitting multiple sclerosis (MS)(1). Cladribine Tablets will be registered in Australia under the trade name Movectro®.
"Approval of Cladribine Tablets in Australia is another step forward here to read article
Bookmark and Share
Enhanced by Zemanta